PDT JOHN HANCOCK PREMIUM DIVIDEND FUND Insider Trading

Director Christine Hurtsellers purchases 912 shares of John Hancock Premium Dividend Fund in open-market transactions.

Director Christine Hurtsellers acquired approximately 912 shares across three open-market transactions on the same day, totaling roughly $12,000. The purchases occurred while the stock was trading modestly below its recent highs and essentially flat over the prior three months, suggesting no particular market momentum preceded the buying. As a director with direct board-level visibility into company operations and strategy, her willingness to deploy capital at current levels indicates comfort with the fund's direction, though the modest size of the purchase and lack of exceptional price weakness mean this is a measured rather than aggressive commitment. For a closed-end fund focused on dividend income, director purchases can signal confidence in the portfolio positioning and yield sustainability, though the lack of supporting context around recent performance or strategic shifts limits the intensity of the conviction signal.

Director Phelan Kenneth J bought 774 shares of PDT at $12.92, establishing first position

Kenneth J Phelan, a Director, purchased 774 shares of John Hancock Premium Dividend Fund at $12.92 on 2026-01-26, totaling $10,001.00, representing his first holding in the security (prior holdings: 0 shares). The purchase price of $12.92 is 0.08% above the current market price of $12.91 and sits within the 52-week range of $11.70–$13.48, positioned 4.2% below the 52-week high. Phelan's cross-ticker track record shows 11 prior open-market purchases with an average 90-day return of +10.8% and a 90-day win rate of 100.00%, though this represents performance across different securities and does not establish predictive value for this particular closed-end fund position.

Director Wright Thomas Rowe buys 929 shares of PDT at $11.85; first position in fund

Wright Thomas Rowe purchased 929 shares of John Hancock Premium Dividend Fund at $11.85 on 2025-04-08, establishing an initial position totaling $11,006.33. The purchase price sits 3.6% below the current price of $12.29 and near the midpoint of the 52-week range of $10.73–$13.54. This is a routine initial investment in a dividend-focused closed-end fund by a director with 7 prior open-market purchases across other holdings. The transaction reflects discretionary capital allocation but lacks distinctive timing or scale characteristics relative to the fund's recent price action and the insider's broader trading history.

Bacic William K bought 800 shares of PDT at $12.55 on 2025-01-14 ($10.0K), first purchase in the fund.

Bacic William K purchased 800 shares of John Hancock Premium Dividend Fund at $12.55, establishing an initial position in the fund. The transaction occurs at a price -6.0% from the 52-week high of $13.54, near the midpoint of the 52-week range ($10.46–$13.54). This represents the insider's first open-market purchase of PDT, following a track record of 8 prior buys across other securities. The modest transaction size ($10.0K) and entry into a closed-end dividend fund warrant standard monitoring, though the absence of prior PDT trades limits inference of insider conviction specific to this holding.

Ellison Noni L bought 890 shares of John Hancock Premium Dividend Fund at $12.64, increasing holdings 74.0% to 2,093 shares

Ellison Noni L purchased 890 shares of PDT on 2024-12-23 at $12.64, a material addition that raised her holdings by 74.0% from 1,203 to 2,093 shares. The prior buy at this ticker on 2023-10-12 generated a 90-day return of +17.7%, establishing a positive precedent for buys at PDT. However, the current purchase occurs while the stock trades 7.1% below its 52-week high and has declined 3.2% over the preceding 30 days and 6.3% over 90 days, a notably weaker entry window relative to the timing of her prior PDT transaction. The transaction signals continued conviction in the holding, though the recent price deterioration and the insider's modest cross-ticker historical buy win rate merit observation.